Spots Global Cancer Trial Database for avastin® (bevacizumab, reference product)
Every month we try and update this database with for avastin® (bevacizumab, reference product) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients | NCT02069704 | Metastatic Colo... | Bevacizumab bio... Avastin® (bevac... | 18 Years - | mAbxience Research S.L. | |
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients | NCT02069704 | Metastatic Colo... | Bevacizumab bio... Avastin® (bevac... | 18 Years - | mAbxience Research S.L. | |
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients | NCT02069704 | Metastatic Colo... | Bevacizumab bio... Avastin® (bevac... | 18 Years - | mAbxience Research S.L. |